Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.34 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3226475 | 0.74 | — | — | |
| SCHEMBL1783601 | 0.74 | — | — | |
| SCHEMBL3468951 | 0.72 | LMNA (0.46) | THRBLMNAMAPTALDH1A1GAA | |
| SCHEMBL20768164 | 0.67 | ALDH1A1 (0.35) | LMNAALDH1A1 | |
| SCHEMBL25501670 | 0.66 | CA5A (0.30) | — | |
| SCHEMBL9511626 | 0.66 | DPP4 (0.34) | — | |
| SCHEMBL13943541 | 0.64 | LMNA (0.36) | LMNA | |
| SCHEMBL13968000 | 0.64 | LMNA (0.36) | LMNAPOLB | |
| SCHEMBL19161154 | 0.63 | KDM1A (0.36) | LMNAMAPTALDH1A1HTTMEN1 | |
| SCHEMBL21300744 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2216324-B1 | Condensed amino nitroguanidine compounds, synthesis and use as botanical insecticides thereof | QIN ZHAOHAI (CN) | 2013-03-13 | — | — | EP | disclosed |
| US-20110306639-A1 | HYDROCARBYLIDENE NITROHYDROZINECARBOXIMIDAMIDES AND A METHOD FOR MAKING THE SAME, AS WELL AS THEIR USES AS AN INSECTICIDE | QIN ZHAOHAI (CN) | 2011-12-15 | — | — | US | disclosed |
| EP-2216324-A1 | CONDENSED AMINO NITROGUANIDINE COMPOUNDS, SYNTHESIS AND USE AS BOTANICAL INSECTICIDES THEREOF | Qin, ZhaoHai (CN) | 2010-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306639-A1 | HYDROCARBYLIDENE NITROHYDROZINECARBOXIMIDAMIDES AND A METHOD FOR MAKING THE SAME, AS WELL AS THEIR USES AS AN INSECTICIDE | CBR3, CBR1, HRH4 | THRB 2015/4885LMNA 4598/4885MAPT 4695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.